Osteopenia: Debates and Dilemmas

被引：0
|
作者：
Jie Zhang
Sarah L. Morgan
Kenneth G. Saag
机构：
[1] University of Alabama at Birmingham,Department of Epidemiology
[2] University of Alabama at Birmingham,Division of Clinical Immunology and Rheumatology
来源：
Current Rheumatology Reports | 2013年 / 15卷
关键词：
Osteopenia; Pharmacologic treatment; Debates; Epidemiology; Fracture risk; FRAX; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Whether or not to use pharmacologic agents for primary prevention of fracture among elderly men and women with osteopenia is debated by clinicians. In this review we provide an update to enable better understanding and characterization of this population, including the prevalence of osteopenia, transitioning from osteopenia to osteoporosis, and clinically applicable tools for fracture risk assessment. We also emphasize the very limited evidence of the benefits and risks of anti-osteoporotic agents for this population for primary fracture prevention, and the need for future studies to guide clinical practice.
引用
收藏
相关论文
共 50 条
12345